Table of Content

1 Report Overview
1.1 Glucagon Like Peptide 2 Receptor Definition
1.2 Market by Type
1.2.1 Global Glucagon Like Peptide 2 Receptor Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 FE-203799
1.2.3 Glepaglutide
1.2.4 GXG-8
1.2.5 HM-15910
1.2.6 Others
1.3 Market Segment by Application
1.3.1 Global Glucagon Like Peptide 2 Receptor Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Short Bowel Syndrome
1.3.3 Diabetes
1.3.4 Diarrhea
1.3.5 Obesity
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Glucagon Like Peptide 2 Receptor Sales
2.1 Global Glucagon Like Peptide 2 Receptor Revenue Estimates and Forecasts 2018-2034
2.2 Global Glucagon Like Peptide 2 Receptor Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global Glucagon Like Peptide 2 Receptor Revenue by Region
2.3.1 Global Glucagon Like Peptide 2 Receptor Revenue by Region (2018-2023)
2.3.2 Global Glucagon Like Peptide 2 Receptor Revenue by Region (2024-2034)
2.4 Global Glucagon Like Peptide 2 Receptor Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Glucagon Like Peptide 2 Receptor Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global Glucagon Like Peptide 2 Receptor Sales Quantity by Region
2.6.1 Global Glucagon Like Peptide 2 Receptor Sales Quantity by Region (2018-2023)
2.6.2 Global Glucagon Like Peptide 2 Receptor Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Glucagon Like Peptide 2 Receptor Sales Quantity by Manufacturers
3.1.1 Global Glucagon Like Peptide 2 Receptor Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Glucagon Like Peptide 2 Receptor Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Glucagon Like Peptide 2 Receptor Sales in 2024
3.2 Global Glucagon Like Peptide 2 Receptor Revenue by Manufacturers
3.2.1 Global Glucagon Like Peptide 2 Receptor Revenue by Manufacturers (2018-2023)
3.2.2 Global Glucagon Like Peptide 2 Receptor Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Glucagon Like Peptide 2 Receptor Revenue in 2024
3.3 Global Glucagon Like Peptide 2 Receptor Sales Price by Manufacturers
3.4 Global Key Players of Glucagon Like Peptide 2 Receptor, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Glucagon Like Peptide 2 Receptor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Glucagon Like Peptide 2 Receptor, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Glucagon Like Peptide 2 Receptor, Product Offered and Application
3.8 Global Key Manufacturers of Glucagon Like Peptide 2 Receptor, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Glucagon Like Peptide 2 Receptor Sales Quantity by Type
4.1.1 Global Glucagon Like Peptide 2 Receptor Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Glucagon Like Peptide 2 Receptor Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Glucagon Like Peptide 2 Receptor Sales Quantity Market Share by Type (2018-2034)
4.2 Global Glucagon Like Peptide 2 Receptor Revenue by Type
4.2.1 Global Glucagon Like Peptide 2 Receptor Historical Revenue by Type (2018-2023)
4.2.2 Global Glucagon Like Peptide 2 Receptor Forecasted Revenue by Type (2024-2034)
4.2.3 Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Type (2018-2034)
4.3 Global Glucagon Like Peptide 2 Receptor Price by Type
4.3.1 Global Glucagon Like Peptide 2 Receptor Price by Type (2018-2023)
4.3.2 Global Glucagon Like Peptide 2 Receptor Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Glucagon Like Peptide 2 Receptor Sales Quantity by Application
5.1.1 Global Glucagon Like Peptide 2 Receptor Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Glucagon Like Peptide 2 Receptor Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Glucagon Like Peptide 2 Receptor Sales Quantity Market Share by Application (2018-2034)
5.2 Global Glucagon Like Peptide 2 Receptor Revenue by Application
5.2.1 Global Glucagon Like Peptide 2 Receptor Historical Revenue by Application (2018-2023)
5.2.2 Global Glucagon Like Peptide 2 Receptor Forecasted Revenue by Application (2024-2034)
5.2.3 Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Application (2018-2034)
5.3 Global Glucagon Like Peptide 2 Receptor Price by Application
5.3.1 Global Glucagon Like Peptide 2 Receptor Price by Application (2018-2023)
5.3.2 Global Glucagon Like Peptide 2 Receptor Price Forecast by Application (2024-2034)
6 North America
6.1 North America Glucagon Like Peptide 2 Receptor Sales by Company
6.1.1 North America Glucagon Like Peptide 2 Receptor Revenue by Company (2018-2023)
6.1.2 North America Glucagon Like Peptide 2 Receptor Sales Quantity by Company (2018-2023)
6.2 North America Glucagon Like Peptide 2 Receptor Market Size by Type
6.2.1 North America Glucagon Like Peptide 2 Receptor Sales Quantity by Type (2018-2034)
6.2.2 North America Glucagon Like Peptide 2 Receptor Revenue by Type (2018-2034)
6.3 North America Glucagon Like Peptide 2 Receptor Market Size by Application
6.3.1 North America Glucagon Like Peptide 2 Receptor Sales Quantity by Application (2018-2034)
6.3.2 North America Glucagon Like Peptide 2 Receptor Revenue by Application (2018-2034)
6.4 North America Glucagon Like Peptide 2 Receptor Market Size by Country
6.4.1 North America Glucagon Like Peptide 2 Receptor Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America Glucagon Like Peptide 2 Receptor Revenue by Country (2018-2034)
6.4.3 North America Glucagon Like Peptide 2 Receptor Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Glucagon Like Peptide 2 Receptor Sales by Company
7.1.1 Europe Glucagon Like Peptide 2 Receptor Sales Quantity by Company (2018-2023)
7.1.2 Europe Glucagon Like Peptide 2 Receptor Revenue by Company (2018-2023)
7.2 Europe Glucagon Like Peptide 2 Receptor Market Size by Type
7.2.1 Europe Glucagon Like Peptide 2 Receptor Sales Quantity by Type (2018-2034)
7.2.2 Europe Glucagon Like Peptide 2 Receptor Revenue by Type (2018-2034)
7.3 Europe Glucagon Like Peptide 2 Receptor Market Size by Application
7.3.1 Europe Glucagon Like Peptide 2 Receptor Sales Quantity by Application (2018-2034)
7.3.2 Europe Glucagon Like Peptide 2 Receptor Revenue by Application (2018-2034)
7.4 Europe Glucagon Like Peptide 2 Receptor Market Size by Country
7.4.1 Europe Glucagon Like Peptide 2 Receptor Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Glucagon Like Peptide 2 Receptor Revenue by Country (2018-2034)
7.4.3 Europe Glucagon Like Peptide 2 Receptor Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Glucagon Like Peptide 2 Receptor Sales by Company
8.1.1 China Glucagon Like Peptide 2 Receptor Sales Quantity by Company (2018-2023)
8.1.2 China Glucagon Like Peptide 2 Receptor Revenue by Company (2018-2023)
8.2 China Glucagon Like Peptide 2 Receptor Market Size by Type
8.2.1 China Glucagon Like Peptide 2 Receptor Sales Quantity by Type (2018-2034)
8.2.2 China Glucagon Like Peptide 2 Receptor Revenue by Type (2018-2034)
8.3 China Glucagon Like Peptide 2 Receptor Market Size by Application
8.3.1 China Glucagon Like Peptide 2 Receptor Sales Quantity by Application (2018-2034)
8.3.2 China Glucagon Like Peptide 2 Receptor Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Glucagon Like Peptide 2 Receptor Sales by Company
9.1.1 APAC Glucagon Like Peptide 2 Receptor Sales Quantity by Company (2018-2023)
9.1.2 APAC Glucagon Like Peptide 2 Receptor Revenue by Company (2018-2023)
9.2 APAC Glucagon Like Peptide 2 Receptor Market Size by Type
9.2.1 APAC Glucagon Like Peptide 2 Receptor Sales Quantity by Type (2018-2034)
9.2.2 APAC Glucagon Like Peptide 2 Receptor Revenue by Type (2018-2034)
9.3 APAC Glucagon Like Peptide 2 Receptor Market Size by Application
9.3.1 APAC Glucagon Like Peptide 2 Receptor Sales Quantity by Application (2018-2034)
9.3.2 APAC Glucagon Like Peptide 2 Receptor Revenue by Application (2018-2034)
9.4 APAC Glucagon Like Peptide 2 Receptor Market Size by Region
9.4.1 APAC Glucagon Like Peptide 2 Receptor Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC Glucagon Like Peptide 2 Receptor Revenue by Region (2018-2034)
9.4.3 APAC Glucagon Like Peptide 2 Receptor Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Glucagon Like Peptide 2 Receptor Sales by Company
10.1.1 Middle East, Africa and Latin America Glucagon Like Peptide 2 Receptor Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Glucagon Like Peptide 2 Receptor Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Glucagon Like Peptide 2 Receptor Market Size by Type
10.2.1 Middle East, Africa and Latin America Glucagon Like Peptide 2 Receptor Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Glucagon Like Peptide 2 Receptor Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Glucagon Like Peptide 2 Receptor Market Size by Application
10.3.1 Middle East, Africa and Latin America Glucagon Like Peptide 2 Receptor Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Glucagon Like Peptide 2 Receptor Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Glucagon Like Peptide 2 Receptor Market Size by Country
10.4.1 Middle East, Africa and Latin America Glucagon Like Peptide 2 Receptor Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America Glucagon Like Peptide 2 Receptor Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Glucagon Like Peptide 2 Receptor Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Hanmi Pharmaceuticals Co Ltd
11.1.1 Hanmi Pharmaceuticals Co Ltd Company Information
11.1.2 Hanmi Pharmaceuticals Co Ltd Overview
11.1.3 Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Products and Services
11.1.5 Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor SWOT Analysis
11.1.6 Hanmi Pharmaceuticals Co Ltd Recent Developments
11.2 Naia Ltd
11.2.1 Naia Ltd Company Information
11.2.2 Naia Ltd Overview
11.2.3 Naia Ltd Glucagon Like Peptide 2 Receptor Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 Naia Ltd Glucagon Like Peptide 2 Receptor Products and Services
11.2.5 Naia Ltd Glucagon Like Peptide 2 Receptor SWOT Analysis
11.2.6 Naia Ltd Recent Developments
11.3 Takeda
11.3.1 Takeda Company Information
11.3.2 Takeda Overview
11.3.3 Takeda Glucagon Like Peptide 2 Receptor Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 Takeda Glucagon Like Peptide 2 Receptor Products and Services
11.3.5 Takeda Glucagon Like Peptide 2 Receptor SWOT Analysis
11.3.6 Takeda Recent Developments
11.4 Tasly Pharmaceutical Group Co Ltd
11.4.1 Tasly Pharmaceutical Group Co Ltd Company Information
11.4.2 Tasly Pharmaceutical Group Co Ltd Overview
11.4.3 Tasly Pharmaceutical Group Co Ltd Glucagon Like Peptide 2 Receptor Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 Tasly Pharmaceutical Group Co Ltd Glucagon Like Peptide 2 Receptor Products and Services
11.4.5 Tasly Pharmaceutical Group Co Ltd Glucagon Like Peptide 2 Receptor SWOT Analysis
11.4.6 Tasly Pharmaceutical Group Co Ltd Recent Developments
11.5 Zealand Pharma AS
11.5.1 Zealand Pharma AS Company Information
11.5.2 Zealand Pharma AS Overview
11.5.3 Zealand Pharma AS Glucagon Like Peptide 2 Receptor Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 Zealand Pharma AS Glucagon Like Peptide 2 Receptor Products and Services
11.5.5 Zealand Pharma AS Glucagon Like Peptide 2 Receptor SWOT Analysis
11.5.6 Zealand Pharma AS Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Glucagon Like Peptide 2 Receptor Value Chain Analysis
12.2 Glucagon Like Peptide 2 Receptor Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Glucagon Like Peptide 2 Receptor Production Mode & Process
12.4 Glucagon Like Peptide 2 Receptor Sales and Marketing
12.4.1 Glucagon Like Peptide 2 Receptor Sales Channels
12.4.2 Glucagon Like Peptide 2 Receptor Distributors
12.5 Glucagon Like Peptide 2 Receptor Customers
13 Market Dynamics
13.1 Glucagon Like Peptide 2 Receptor Industry Trends
13.2 Glucagon Like Peptide 2 Receptor Market Drivers
13.3 Glucagon Like Peptide 2 Receptor Market Challenges
13.4 Glucagon Like Peptide 2 Receptor Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Glucagon Like Peptide 2 Receptor Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of FE-203799
Table 3. Major Manufacturers of Glepaglutide
Table 4. Major Manufacturers of GXG-8
Table 5. Major Manufacturers of HM-15910
Table 6. Major Manufacturers of Others
Table 7. Global Glucagon Like Peptide 2 Receptor Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Glucagon Like Peptide 2 Receptor Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. Global Glucagon Like Peptide 2 Receptor Revenue by Region (2018-2023) & (US$ Million)
Table 10. Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Region (2018-2023)
Table 11. Global Glucagon Like Peptide 2 Receptor Revenue by Region (2024-2034) & (US$ Million)
Table 12. Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Region (2024-2034)
Table 13. Global Glucagon Like Peptide 2 Receptor Sales Quantity by Region: 2018 VS 2024 VS 2034 (K Pcs)
Table 14. Global Glucagon Like Peptide 2 Receptor Sales by Region (2018-2023) & (K Pcs)
Table 15. Global Glucagon Like Peptide 2 Receptor Sales Market Share by Region (2018-2023)
Table 16. Global Glucagon Like Peptide 2 Receptor Sales by Region (2024-2034) & (K Pcs)
Table 17. Global Glucagon Like Peptide 2 Receptor Sales Market Share by Region (2024-2034)
Table 18. Global Glucagon Like Peptide 2 Receptor Sales Quantity by Manufacturers (2018-2023) & (K Pcs)
Table 19. Global Glucagon Like Peptide 2 Receptor Sales Quantity Share by Manufacturers (2018-2023)
Table 20. Global Glucagon Like Peptide 2 Receptor Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 21. Global Glucagon Like Peptide 2 Receptor Revenue Share by Manufacturers (2018-2023)
Table 22. Global Glucagon Like Peptide 2 Receptor Price by Manufacturers 2018-2023 (USD/Pcs)
Table 23. Global Key Players of Glucagon Like Peptide 2 Receptor, Industry Ranking, 2021 VS 2024
Table 24. Global Glucagon Like Peptide 2 Receptor Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Glucagon Like Peptide 2 Receptor by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glucagon Like Peptide 2 Receptor as of 2024)
Table 26. Global Key Manufacturers of Glucagon Like Peptide 2 Receptor, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of Glucagon Like Peptide 2 Receptor, Product Offered and Application
Table 28. Global Key Manufacturers of Glucagon Like Peptide 2 Receptor, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Glucagon Like Peptide 2 Receptor Sales Quantity by Type (2018-2023) & (K Pcs)
Table 31. Global Glucagon Like Peptide 2 Receptor Sales Quantity by Type (2024-2034) & (K Pcs)
Table 32. Global Glucagon Like Peptide 2 Receptor Sales Quantity Share by Type (2018-2023)
Table 33. Global Glucagon Like Peptide 2 Receptor Sales Quantity Share by Type (2024-2034)
Table 34. Global Glucagon Like Peptide 2 Receptor Revenue by Type (2018-2023) & (US$ Million)
Table 35. Global Glucagon Like Peptide 2 Receptor Revenue by Type (2024-2034) & (US$ Million)
Table 36. Global Glucagon Like Peptide 2 Receptor Revenue Share by Type (2018-2023)
Table 37. Global Glucagon Like Peptide 2 Receptor Revenue Share by Type (2024-2034)
Table 38. Glucagon Like Peptide 2 Receptor Price by Type (2018-2023) & (USD/Pcs)
Table 39. Global Glucagon Like Peptide 2 Receptor Price Forecast by Type (2024-2034) & (USD/Pcs)
Table 40. Global Glucagon Like Peptide 2 Receptor Sales Quantity by Application (2018-2023) & (K Pcs)
Table 41. Global Glucagon Like Peptide 2 Receptor Sales Quantity by Application (2024-2034) & (K Pcs)
Table 42. Global Glucagon Like Peptide 2 Receptor Sales Quantity Share by Application (2018-2023)
Table 43. Global Glucagon Like Peptide 2 Receptor Sales Quantity Share by Application (2024-2034)
Table 44. Global Glucagon Like Peptide 2 Receptor Revenue by Application (2018-2023) & (US$ Million)
Table 45. Global Glucagon Like Peptide 2 Receptor Revenue by Application (2024-2034) & (US$ Million)
Table 46. Global Glucagon Like Peptide 2 Receptor Revenue Share by Application (2018-2023)
Table 47. Global Glucagon Like Peptide 2 Receptor Revenue Share by Application (2024-2034)
Table 48. Glucagon Like Peptide 2 Receptor Price by Application (2018-2023) & (USD/Pcs)
Table 49. Global Glucagon Like Peptide 2 Receptor Price Forecast by Application (2024-2034) & (USD/Pcs)
Table 50. North America Glucagon Like Peptide 2 Receptor Revenue by Company (2018-2023) & (US$ Million)
Table 51. North America Glucagon Like Peptide 2 Receptor Sales Quantity by Company (2018-2023) & (K Pcs)
Table 52. North America Glucagon Like Peptide 2 Receptor Sales Quantity by Type (2018-2023) & (K Pcs)
Table 53. North America Glucagon Like Peptide 2 Receptor Sales Quantity by Type (2024-2034) & (K Pcs)
Table 54. North America Glucagon Like Peptide 2 Receptor Revenue by Type (2018-2023) & (US$ Million)
Table 55. North America Glucagon Like Peptide 2 Receptor Revenue by Type (2024-2034) & (US$ Million)
Table 56. North America Glucagon Like Peptide 2 Receptor Sales Quantity by Application (2018-2023) & (K Pcs)
Table 57. North America Glucagon Like Peptide 2 Receptor Sales Quantity by Application (2024-2034) & (K Pcs)
Table 58. North America Glucagon Like Peptide 2 Receptor Revenue by Application (2018-2023) & (US$ Million)
Table 59. North America Glucagon Like Peptide 2 Receptor Revenue by Application (2024-2034) & (US$ Million)
Table 60. North America Glucagon Like Peptide 2 Receptor Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 61. North America Glucagon Like Peptide 2 Receptor Revenue by Country (2018-2023) & (US$ Million)
Table 62. North America Glucagon Like Peptide 2 Receptor Revenue by Country (2024-2034) & (US$ Million)
Table 63. North America Glucagon Like Peptide 2 Receptor Sales Quantity by Country (2018-2023) & (K Pcs)
Table 64. North America Glucagon Like Peptide 2 Receptor Sales Quantity by Country (2024-2034) & (K Pcs)
Table 65. Europe Glucagon Like Peptide 2 Receptor Sales Quantity by Company (2018-2023) & (K Pcs)
Table 66. Europe Glucagon Like Peptide 2 Receptor Revenue by Company (2018-2023) & (US$ Million)
Table 67. Europe Glucagon Like Peptide 2 Receptor Sales Quantity by Type (2018-2023) & (K Pcs)
Table 68. Europe Glucagon Like Peptide 2 Receptor Sales Quantity by Type (2024-2034) & (K Pcs)
Table 69. Europe Glucagon Like Peptide 2 Receptor Revenue by Type (2018-2023) & (US$ Million)
Table 70. Europe Glucagon Like Peptide 2 Receptor Revenue by Type (2024-2034) & (US$ Million)
Table 71. Europe Glucagon Like Peptide 2 Receptor Sales Quantity by Application (2018-2023) & (K Pcs)
Table 72. Europe Glucagon Like Peptide 2 Receptor Sales Quantity by Application (2024-2034) & (K Pcs)
Table 73. Europe Glucagon Like Peptide 2 Receptor Revenue by Application (2018-2023) & (US$ Million)
Table 74. Europe Glucagon Like Peptide 2 Receptor Revenue by Application (2024-2034) & (US$ Million)
Table 75. Europe Glucagon Like Peptide 2 Receptor Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 76. Europe Glucagon Like Peptide 2 Receptor Revenue by Country (2018-2023) & (US$ Million)
Table 77. Europe Glucagon Like Peptide 2 Receptor Revenue by Country (2024-2034) & (US$ Million)
Table 78. Europe Glucagon Like Peptide 2 Receptor Sales Quantity by Country (2018-2023) & (K Pcs)
Table 79. Europe Glucagon Like Peptide 2 Receptor Sales Quantity by Country (2024-2034) & (K Pcs)
Table 80. China Glucagon Like Peptide 2 Receptor Sales Quantity by Company (2018-2023) & (K Pcs)
Table 81. China Glucagon Like Peptide 2 Receptor Revenue by Company (2018-2023) & (US$ Million)
Table 82. China Glucagon Like Peptide 2 Receptor Sales Quantity by Type (2018-2023) & (K Pcs)
Table 83. China Glucagon Like Peptide 2 Receptor Sales Quantity by Type (2024-2034) & (K Pcs)
Table 84. China Glucagon Like Peptide 2 Receptor Revenue by Type (2018-2023) & (US$ Million)
Table 85. China Glucagon Like Peptide 2 Receptor Revenue by Type (2024-2034) & (US$ Million)
Table 86. China Glucagon Like Peptide 2 Receptor Sales Quantity by Application (2018-2023) & (K Pcs)
Table 87. China Glucagon Like Peptide 2 Receptor Sales Quantity by Application (2024-2034) & (K Pcs)
Table 88. China Glucagon Like Peptide 2 Receptor Revenue by Application (2018-2023) & (US$ Million)
Table 89. China Glucagon Like Peptide 2 Receptor Revenue by Application (2024-2034) & (US$ Million)
Table 90. APAC Glucagon Like Peptide 2 Receptor Sales Quantity by Company (2018-2023) & (K Pcs)
Table 91. APAC Glucagon Like Peptide 2 Receptor Revenue by Company (2018-2023) & (US$ Million)
Table 92. APAC Glucagon Like Peptide 2 Receptor Sales Quantity by Type (2018-2023) & (K Pcs)
Table 93. APAC Glucagon Like Peptide 2 Receptor Sales Quantity by Type (2024-2034) & (K Pcs)
Table 94. APAC Glucagon Like Peptide 2 Receptor Revenue by Type (2018-2023) & (US$ Million)
Table 95. APAC Glucagon Like Peptide 2 Receptor Revenue by Type (2024-2034) & (US$ Million)
Table 96. APAC Glucagon Like Peptide 2 Receptor Sales Quantity by Application (2018-2023) & (K Pcs)
Table 97. APAC Glucagon Like Peptide 2 Receptor Sales Quantity by Application (2024-2034) & (K Pcs)
Table 98. APAC Glucagon Like Peptide 2 Receptor Revenue by Application (2018-2023) & (US$ Million)
Table 99. APAC Glucagon Like Peptide 2 Receptor Revenue by Application (2024-2034) & (US$ Million)
Table 100. APAC Glucagon Like Peptide 2 Receptor Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 101. APAC Glucagon Like Peptide 2 Receptor Revenue by Region (2018-2023) & (US$ Million)
Table 102. APAC Glucagon Like Peptide 2 Receptor Revenue by Region (2024-2034) & (US$ Million)
Table 103. APAC Glucagon Like Peptide 2 Receptor Sales Quantity by Region (2018-2023) & (K Pcs)
Table 104. APAC Glucagon Like Peptide 2 Receptor Sales Quantity by Region (2024-2034) & (K Pcs)
Table 105. Middle East, Africa and Latin America Glucagon Like Peptide 2 Receptor Sales Quantity by Company (2018-2023) & (K Pcs)
Table 106. Middle East, Africa and Latin America Glucagon Like Peptide 2 Receptor Revenue by Company (2018-2023) & (US$ Million)
Table 107. Middle East, Africa and Latin America Glucagon Like Peptide 2 Receptor Sales Quantity by Type (2018-2023) & (K Pcs)
Table 108. Middle East, Africa and Latin America Glucagon Like Peptide 2 Receptor Sales Quantity by Type (2024-2034) & (K Pcs)
Table 109. Middle East, Africa and Latin America Glucagon Like Peptide 2 Receptor Revenue by Type (2018-2023) & (US$ Million)
Table 110. Middle East, Africa and Latin America Glucagon Like Peptide 2 Receptor Revenue by Type (2024-2034) & (US$ Million)
Table 111. Middle East, Africa and Latin America Glucagon Like Peptide 2 Receptor Sales Quantity by Application (2018-2023) & (K Pcs)
Table 112. Middle East, Africa and Latin America Glucagon Like Peptide 2 Receptor Sales Quantity by Application (2024-2034) & (K Pcs)
Table 113. Middle East, Africa and Latin America Glucagon Like Peptide 2 Receptor Revenue by Application (2018-2023) & (US$ Million)
Table 114. Middle East, Africa and Latin America Glucagon Like Peptide 2 Receptor Revenue by Application (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Glucagon Like Peptide 2 Receptor Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 116. Middle East, Africa and Latin America Glucagon Like Peptide 2 Receptor Revenue by Country (2018-2023) & (US$ Million)
Table 117. Middle East, Africa and Latin America Glucagon Like Peptide 2 Receptor Revenue by Country (2024-2034) & (US$ Million)
Table 118. Middle East, Africa and Latin America Glucagon Like Peptide 2 Receptor Sales Quantity by Country (2018-2023) & (K Pcs)
Table 119. Middle East, Africa and Latin America Glucagon Like Peptide 2 Receptor Sales Quantity by Country (2024-2034) & (K Pcs)
Table 120. Hanmi Pharmaceuticals Co Ltd Company Information
Table 121. Hanmi Pharmaceuticals Co Ltd Description and Overview
Table 122. Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 123. Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Product and Services
Table 124. Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor SWOT Analysis
Table 125. Hanmi Pharmaceuticals Co Ltd Recent Developments
Table 126. Naia Ltd Company Information
Table 127. Naia Ltd Description and Overview
Table 128. Naia Ltd Glucagon Like Peptide 2 Receptor Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 129. Naia Ltd Glucagon Like Peptide 2 Receptor Product and Services
Table 130. Naia Ltd Glucagon Like Peptide 2 Receptor SWOT Analysis
Table 131. Naia Ltd Recent Developments
Table 132. Takeda Company Information
Table 133. Takeda Description and Overview
Table 134. Takeda Glucagon Like Peptide 2 Receptor Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 135. Takeda Glucagon Like Peptide 2 Receptor Product and Services
Table 136. Takeda Glucagon Like Peptide 2 Receptor SWOT Analysis
Table 137. Takeda Recent Developments
Table 138. Tasly Pharmaceutical Group Co Ltd Company Information
Table 139. Tasly Pharmaceutical Group Co Ltd Description and Overview
Table 140. Tasly Pharmaceutical Group Co Ltd Glucagon Like Peptide 2 Receptor Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 141. Tasly Pharmaceutical Group Co Ltd Glucagon Like Peptide 2 Receptor Product and Services
Table 142. Tasly Pharmaceutical Group Co Ltd Glucagon Like Peptide 2 Receptor SWOT Analysis
Table 143. Tasly Pharmaceutical Group Co Ltd Recent Developments
Table 144. Zealand Pharma AS Company Information
Table 145. Zealand Pharma AS Description and Overview
Table 146. Zealand Pharma AS Glucagon Like Peptide 2 Receptor Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 147. Zealand Pharma AS Glucagon Like Peptide 2 Receptor Product and Services
Table 148. Zealand Pharma AS Glucagon Like Peptide 2 Receptor SWOT Analysis
Table 149. Zealand Pharma AS Recent Developments
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Glucagon Like Peptide 2 Receptor Distributors List
Table 153. Glucagon Like Peptide 2 Receptor Customers List
Table 154. Glucagon Like Peptide 2 Receptor Market Trends
Table 155. Glucagon Like Peptide 2 Receptor Market Drivers
Table 156. Glucagon Like Peptide 2 Receptor Market Challenges
Table 157. Glucagon Like Peptide 2 Receptor Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Glucagon Like Peptide 2 Receptor Product Picture
Figure 2. Global Glucagon Like Peptide 2 Receptor Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Glucagon Like Peptide 2 Receptor Market Share by Type in 2024 & 2034
Figure 4. FE-203799 Product Picture
Figure 5. Glepaglutide Product Picture
Figure 6. GXG-8 Product Picture
Figure 7. HM-15910 Product Picture
Figure 8. Others Product Picture
Figure 9. Global Glucagon Like Peptide 2 Receptor Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 10. Global Glucagon Like Peptide 2 Receptor Market Share by Application in 2024 & 2034
Figure 11. Short Bowel Syndrome
Figure 12. Diabetes
Figure 13. Diarrhea
Figure 14. Obesity
Figure 15. Others
Figure 16. Glucagon Like Peptide 2 Receptor Report Years Considered
Figure 17. Global Glucagon Like Peptide 2 Receptor Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 18. Global Glucagon Like Peptide 2 Receptor Revenue 2018-2034 (US$ Million)
Figure 19. Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 20. Global Glucagon Like Peptide 2 Receptor Sales Quantity 2018-2034 (K Pcs)
Figure 21. Global Glucagon Like Peptide 2 Receptor Sales Quantity Market Share by Region (2018-2023)
Figure 22. Global Glucagon Like Peptide 2 Receptor Sales Quantity Market Share by Region (2024-2034)
Figure 23. North America Glucagon Like Peptide 2 Receptor Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 24. North America Glucagon Like Peptide 2 Receptor Revenue YoY (2018-2034) & (US$ Million)
Figure 25. Europe Glucagon Like Peptide 2 Receptor Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 26. Europe Glucagon Like Peptide 2 Receptor Revenue YoY (2018-2034) & (US$ Million)
Figure 27. China Glucagon Like Peptide 2 Receptor Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 28. China Glucagon Like Peptide 2 Receptor Revenue YoY (2018-2034) & (US$ Million)
Figure 29. APAC Glucagon Like Peptide 2 Receptor Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 30. APAC Glucagon Like Peptide 2 Receptor Revenue YoY (2018-2034) & (US$ Million)
Figure 31. Middle East, Africa and Latin America Glucagon Like Peptide 2 Receptor Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 32. Middle East, Africa and Latin America Glucagon Like Peptide 2 Receptor Revenue YoY (2018-2034) & (US$ Million)
Figure 33. The Top 10 and Top 5 Players Market Share by Glucagon Like Peptide 2 Receptor Sales Quantity in 2024
Figure 34. The Top 10 and Top 5 Players Market Share by Glucagon Like Peptide 2 Receptor Revenue in 2024
Figure 35. Glucagon Like Peptide 2 Receptor Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 36. Global Glucagon Like Peptide 2 Receptor Sales Quantity Market Share by Type (2018-2034)
Figure 37. Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Type (2018-2034)
Figure 38. Global Glucagon Like Peptide 2 Receptor Sales Quantity Market Share by Application (2018-2034)
Figure 39. Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Application (2018-2034)
Figure 40. North America Glucagon Like Peptide 2 Receptor Revenue Market Share by Company in 2024
Figure 41. North America Glucagon Like Peptide 2 Receptor Sales Quantity Market Share by Company in 2024
Figure 42. North America Glucagon Like Peptide 2 Receptor Sales Quantity Market Share by Type (2018-2034)
Figure 43. North America Glucagon Like Peptide 2 Receptor Revenue Market Share by Type (2018-2034)
Figure 44. North America Glucagon Like Peptide 2 Receptor Sales Quantity Market Share by Application (2018-2034)
Figure 45. North America Glucagon Like Peptide 2 Receptor Revenue Market Share by Application (2018-2034)
Figure 46. North America Glucagon Like Peptide 2 Receptor Revenue Share by Country (2018-2034)
Figure 47. North America Glucagon Like Peptide 2 Receptor Sales Quantity Share by Country (2018-2034)
Figure 48. U.S. Glucagon Like Peptide 2 Receptor Revenue (2018-2034) & (US$ Million)
Figure 49. Canada Glucagon Like Peptide 2 Receptor Revenue (2018-2034) & (US$ Million)
Figure 50. Europe Glucagon Like Peptide 2 Receptor Sales Quantity Market Share by Company in 2024
Figure 51. Europe Glucagon Like Peptide 2 Receptor Revenue Market Share by Company in 2024
Figure 52. Europe Glucagon Like Peptide 2 Receptor Sales Quantity Market Share by Type (2018-2034)
Figure 53. Europe Glucagon Like Peptide 2 Receptor Revenue Market Share by Type (2018-2034)
Figure 54. Europe Glucagon Like Peptide 2 Receptor Sales Quantity Market Share by Application (2018-2034)
Figure 55. Europe Glucagon Like Peptide 2 Receptor Revenue Market Share by Application (2018-2034)
Figure 56. Europe Glucagon Like Peptide 2 Receptor Revenue Share by Country (2018-2034)
Figure 57. Europe Glucagon Like Peptide 2 Receptor Sales Quantity Share by Country (2018-2034)
Figure 58. Germany Glucagon Like Peptide 2 Receptor Revenue (2018-2034) & (US$ Million)
Figure 59. France Glucagon Like Peptide 2 Receptor Revenue (2018-2034) & (US$ Million)
Figure 60. U.K. Glucagon Like Peptide 2 Receptor Revenue (2018-2034) & (US$ Million)
Figure 61. Italy Glucagon Like Peptide 2 Receptor Revenue (2018-2034) & (US$ Million)
Figure 62. Russia Glucagon Like Peptide 2 Receptor Revenue (2018-2034) & (US$ Million)
Figure 63. China Glucagon Like Peptide 2 Receptor Sales Quantity Market Share by Company in 2024
Figure 64. China Glucagon Like Peptide 2 Receptor Revenue Market Share by Company in 2024
Figure 65. China Glucagon Like Peptide 2 Receptor Sales Quantity Market Share by Type (2018-2034)
Figure 66. China Glucagon Like Peptide 2 Receptor Revenue Market Share by Type (2018-2034)
Figure 67. China Glucagon Like Peptide 2 Receptor Sales Quantity Market Share by Application (2018-2034)
Figure 68. China Glucagon Like Peptide 2 Receptor Revenue Market Share by Application (2018-2034)
Figure 69. APAC Glucagon Like Peptide 2 Receptor Sales Quantity Market Share by Company in 2024
Figure 70. APAC Glucagon Like Peptide 2 Receptor Revenue Market Share by Company in 2024
Figure 71. APAC Glucagon Like Peptide 2 Receptor Sales Quantity Market Share by Type (2018-2034)
Figure 72. APAC Glucagon Like Peptide 2 Receptor Revenue Market Share by Type (2018-2034)
Figure 73. APAC Glucagon Like Peptide 2 Receptor Sales Quantity Market Share by Application (2018-2034)
Figure 74. APAC Glucagon Like Peptide 2 Receptor Revenue Market Share by Application (2018-2034)
Figure 75. APAC Glucagon Like Peptide 2 Receptor Revenue Share by Region (2018-2034)
Figure 76. APAC Glucagon Like Peptide 2 Receptor Sales Quantity Share by Region (2018-2034)
Figure 77. Japan Glucagon Like Peptide 2 Receptor Revenue (2018-2034) & (US$ Million)
Figure 78. South Korea Glucagon Like Peptide 2 Receptor Revenue (2018-2034) & (US$ Million)
Figure 79. China Taiwan Glucagon Like Peptide 2 Receptor Revenue (2018-2034) & (US$ Million)
Figure 80. Southeast Asia Glucagon Like Peptide 2 Receptor Revenue (2018-2034) & (US$ Million)
Figure 81. India Glucagon Like Peptide 2 Receptor Revenue (2018-2034) & (US$ Million)
Figure 82. Middle East, Africa and Latin America Glucagon Like Peptide 2 Receptor Sales Quantity Market Share by Company in 2024
Figure 83. Middle East, Africa and Latin America Glucagon Like Peptide 2 Receptor Revenue Market Share by Company in 2024
Figure 84. Middle East, Africa and Latin America Glucagon Like Peptide 2 Receptor Sales Quantity Market Share by Type (2018-2034)
Figure 85. Middle East, Africa and Latin America Glucagon Like Peptide 2 Receptor Revenue Market Share by Type (2018-2034)
Figure 86. Middle East, Africa and Latin America Glucagon Like Peptide 2 Receptor Sales Quantity Market Share by Application (2018-2034)
Figure 87. Middle East, Africa and Latin America Glucagon Like Peptide 2 Receptor Revenue Market Share by Application (2018-2034)
Figure 88. Middle East, Africa and Latin America Glucagon Like Peptide 2 Receptor Sales Quantity Share by Country (2018-2034)
Figure 89. Middle East, Africa and Latin America Glucagon Like Peptide 2 Receptor Revenue Share by Country (2018-2034)
Figure 90. Brazil Glucagon Like Peptide 2 Receptor Revenue (2018-2034) & (US$ Million)
Figure 91. Mexico Glucagon Like Peptide 2 Receptor Revenue (2018-2034) & (US$ Million)
Figure 92. Turkey Glucagon Like Peptide 2 Receptor Revenue (2018-2034) & (US$ Million)
Figure 93. Israel Glucagon Like Peptide 2 Receptor Revenue (2018-2034) & (US$ Million)
Figure 94. GCC Countries Glucagon Like Peptide 2 Receptor Revenue (2018-2034) & (US$ Million)
Figure 95. Glucagon Like Peptide 2 Receptor Value Chain
Figure 96. Glucagon Like Peptide 2 Receptor Production Process
Figure 97. Channels of Distribution (Direct Vs Distribution)
Figure 98. Distributors Profiles
Figure 99. Bottom-up and Top-down Approaches for This Report
Figure 100. Data Triangulation
Figure 101. Key Executives Interviewed